0       0

39th Annual Meeting and Scientific Sessions


SS29 - RESEARCH SESSION 29: Pediatric Lung Transplantation: Are We Moving Forward?


Apr 4, 2019 8:00am ‐ Apr 4, 2019 9:45am

Description

(121) Pediatric Patients with Pulmonary Vascular and Restrictive Lung Disease Suffer Disproportionately High Waitlist Mortality
Kyle Riggs, MD

(122) Outcomes of Cystic Fibrosis and Non-Cystic Fibrosis Pediatric Lung Transplants: An ISHLT Registry Study
Jennifer Nelson, MD, MS

(123) Pediatric Lung Transplantation: Fit for Split?
Thomas Martens, MD

(124) Etiology of Failure Predicts Heart-Lung Transplant Candidate's Waitlist Survival
Kyle Riggs, MD

(125) Is the Current Era Better for Pediatric Heart-Lung Transplantation?
Kyle Riggs, MD

(126) Proinflammatory Cytokines as Biomarkers for BOS, Death, or Retransplantation after Lung Transplantation
Carol Conrad, MD

(127) Five-Year Experience with Treatment of Early Donor Specific Anti-HLA Antibodies in Pediatric Lung Transplant Recipients
Fabio Ius, MD

Speaker(s):

  • Kyle Riggs, MD, Cincinnati Children's Hospital, Cincinnati, OH, United States
  • Jennifer Nelson, MD, MS, Nemours Children's Hospital, Orlando, FL, United States
  • Thomas Martens, MD, University Hospital, Ghent, Belgium
  • Carol K. Conrad, MD, Lucile Packard Children's Hospital Palo Alto, California, USA
  • Fabio Ius, MD, Hannover Medical School, Hannover, Germany
Tags: PEDS LTX

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content